Impact of attenuation correction for CZT-SPECT measurement of myocardial blood flow.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
12 2021
Historique:
received: 04 12 2019
accepted: 04 02 2020
pubmed: 23 2 2020
medline: 25 3 2022
entrez: 22 2 2020
Statut: ppublish

Résumé

Most of cardiac dedicated CZT-SPECT systems are not equipped with CT, whereas PET systems are. We evaluated the impact of AC correction on CZT-SPECT myocardial blood flow (MBF) and myocardial flow reserve (MFR) measurements. 104 patients were included. SPECT data were acquired on cadmium zinc telluride (CZT)-based pinhole cardiac camera in listmode using a stress (250 ± 17 MBq)/rest (511 ± 23 MBq) 1-day Tc-99m-tetrofosmin protocol. Low-dose CT was acquired on another SPECT/CT camera in the same position. All analysis was performed using Corridor4DM. Stress and rest MBF were significantly lower when AC was applied (P < 0.001). For regional and global MFR, there was no significant difference between AC and NAC measurements (P > 0.25 at least). Mean global LV MFR was 2.43 ± 0.87 and 2.33 ± 0.89, respectively, for NAC and AC measurements. Using a threshold of 2, 86 patients (83%) remained classified as normal and abnormal regarding global LV MFR whether AC was applied or not. Mean difference between NAC and AC values for the 18 other patients was 0.3. AC correction does not significantly affect MFR measurement both in regional and global LV analyses.

Identifiants

pubmed: 32080802
doi: 10.1007/s12350-020-02075-7
pii: 10.1007/s12350-020-02075-7
doi:

Substances chimiques

CdZnTe 0
Cadmium 00BH33GNGH
Zinc J41CSQ7QDS
Tellurium NQA0O090ZJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2560-2568

Informations de copyright

© 2020. American Society of Nuclear Cardiology.

Références

Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med 2009;50:1076-87.
doi: 10.2967/jnumed.108.054478
Valenta I, Dilsizian V, Quercioli A, Ruddy TD, Schindler TH. Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes. Curr Cardiol Rep 2013;15:344.
doi: 10.1007/s11886-012-0344-0
Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.
doi: 10.1016/j.jacc.2009.02.069
Bocher M, Blevis IM, Tsukerman L, Shrem Y, Kovalski G, Volokh L. A fast cardiac gamma camera with dynamic SPECT capabilities: Design, system validation and future potential. Eur J Nucl Med Mol Imaging 2010;37:1887-902.
doi: 10.1007/s00259-010-1488-z
Wells RG, Timmins R, Klein R, Lockwood J, Marvin B, deKemp RA, et al. Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model. J Nucl Med 2014;55:1685-91.
doi: 10.2967/jnumed.114.139782
Nkoulou R, Fuchs TA, Pazhenkottil AP, Kuest SM, Ghadri JR, Stehli J, et al. Absolute myocardial blood flow and flow reserve assessed by gated SPECT with cadmium-zinc-telluride detectors using 99mTc-tetrofosmin: Head-to-head comparison with 13N-ammonia PET. J Nucl Med 2016;57:1887-92.
doi: 10.2967/jnumed.115.165498
Agostini D, Roule V, Nganoa C, Roth N, Baavour R, Parienti JJ, et al. First validation of myocardial flow reserve assessed by dynamic (99m)Tc-sestamibi CZT-SPECT camera: Head to head comparison with (15)O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging 2018;45:1079-90.
doi: 10.1007/s00259-018-3958-7
de Souza A, Goncalves BKD, Tedeschi AL, Lima RSL. Quantification of myocardial flow reserve using a gamma camera with solid-state cadmium-zinc-telluride detectors: Relation to angiographic coronary artery disease. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-019-01775-z .
doi: 10.1007/s12350-019-01775-z pubmed: 31792916
Wells RG, Marvin B, Poirier M, Renaud J, deKemp RA, Ruddy TD. Optimization of SPECT measurement of myocardial blood flow with corrections for attenuation, motion, and blood binding compared with PET. J Nucl Med 2017;58:2013-9.
doi: 10.2967/jnumed.117.191049
Giubbini R, Bertoli M, Durmo R, Bonacina M, Peli A, Faggiano I, et al. Comparison between N(13)NH3-PET and (99m)Tc-Tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-019-01939-x .
doi: 10.1007/s12350-019-01939-x pubmed: 31728817
Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 2007;34:1765-74.
doi: 10.1007/s00259-007-0478-2
Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 1989;65:632-9.
doi: 10.1161/01.RES.65.3.632
Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996;37:1701-12.
pubmed: 8862316
Grossman GB, Garcia EV, Bateman TM, Heller GV, Johnson LL, Folks RD, et al. Quantitative Tc-99m sestamibi attenuation-corrected SPECT: Development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population. J Nucl Cardiol 2004;11:263-72.
doi: 10.1016/j.nuclcard.2004.02.007
Shawgi M, Tonge CM, Lawson RS, Muthu S, James J, Arumugam P. Attenuation correction of myocardial perfusion SPET in patients of normal Body Mass Index. Hell J Nucl Med 2012;15:215-9.
pubmed: 23227459
Gaemperli O, Kaufmann PA, Alkadhi H. Cardiac hybrid imaging. Eur J Nucl Med Mol Imaging 2014;41:S91-103.
doi: 10.1007/s00259-013-2566-9
Tamam M, Mulazimoglu M, Edis N, Ozpacaci T. The value of attenuation correction in hybrid cardiac SPECT/CT on inferior wall according to Body Mass Index. World J Nucl Med 2016;15:18-23.
doi: 10.4103/1450-1147.167586
Heller GV, Bateman TM, Johnson LL, Cullom SJ, Case JA, Galt JR, et al. Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging. J Nucl Cardiol 2004;11:273-81.
doi: 10.1016/j.nuclcard.2004.03.005
Uchibe T, Miyai M, Yata N, Haramoto M, Yamamoto Y, Nakamura M, et al. Evaluation of the effect of attenuation correction by external CT in a semiconductor SPECT. Nihon Hoshasen Gijutsu Gakkai Zasshi 2016;72:610-6.
doi: 10.6009/jjrt.2016_JSRT_72.7.610
Ben-Haim S, Murthy VL, Breault C, Allie R, Sitek A, Roth N, et al. Quantification of myocardial perfusion reserve using dynamic SPECT imaging in humans: A feasibility study. J Nucl Med 2013;54:873-9.
doi: 10.2967/jnumed.112.109652
Shiraishi S, Sakamoto F, Tsuda N, Yoshida M, Tomiguchi S, Utsunomiya D, et al. Prediction of left main or 3-vessel disease using myocardial perfusion reserve on dynamic thallium-201 single-photon emission computed tomography with a semiconductor gamma camera. Circ J 2015;79:623-31.
doi: 10.1253/circj.CJ-14-0932
Ben Bouallegue F, Roubille F, Lattuca B, Cung TT, Macia JC, Gervasoni R, et al. SPECT Myocardial perfusion reserve in patients with multivessel coronary disease: Correlation with angiographic findings and invasive fractional flow reserve measurements. J Nucl Med 2015;56:1712-7.
doi: 10.2967/jnumed.114.143164
Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011;58:740-8.
doi: 10.1016/j.jacc.2011.01.065
Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med 2014;55:248-55.
doi: 10.2967/jnumed.113.121442
Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124:2215-24.
doi: 10.1161/CIRCULATIONAHA.111.050427
Cho SG, Lee SJ, Na MH, Choi YY, Bom HH. Comparison of diagnostic accuracy of PET-derived myocardial blood flow parameters: A meta-analysis. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-01476-z .
doi: 10.1007/s12350-018-01476-z pubmed: 30390243 pmcid: 6488439
Gupta A, Taqueti VR, van de Hoef TP, Bajaj NS, Bravo PE, Murthy VL, et al. Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation 2017;136:2325-36.
doi: 10.1161/CIRCULATIONAHA.117.029992
Hunter CR, Klein R, Beanlands RS, deKemp RA. Patient motion effects on the quantification of regional myocardial blood flow with dynamic PET imaging. Med Phys 2016;43:1829.
doi: 10.1118/1.4943565
Yu Y, Chan C, Ma T, Liu Y, Gallezot JD, Naganawa M, et al. Event-by-event continuous respiratory motion correction for dynamic PET imaging. J Nucl Med 2016;57:1084-90.
doi: 10.2967/jnumed.115.167676
Oliveira JB, Sen YM, Wechalekar K. Intersoftware variability impacts classification of cardiac PET exams. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1444-z .
doi: 10.1007/s12350-018-1444-z pubmed: 30238299
Monroy-Gonzalez AG, Juarez-Orozco LE, Han C, Vedder IR, Garcia DV, Borra R, et al. Software reproducibility of myocardial blood flow and flow reserve quantification in ischemic heart disease: A (13)N-ammonia PET study. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-018-1444-z .
doi: 10.1007/s12350-018-1444-z pubmed: 30903608 pmcid: 6908565
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-81.
doi: 10.1093/eurheartj/ehw106

Auteurs

Matthieu Bailly (M)

Nuclear Medicine Department, CHR ORLEANS, 14 Avenue de l'Hôpital, 45100, Orleans, France. matthieu.bailly@chr-orleans.fr.

Frédérique Thibault (F)

Nuclear Medicine Department, CHR ORLEANS, 14 Avenue de l'Hôpital, 45100, Orleans, France.
Nuclear Medicine Department, CHRU TOURS, Tours, France.

Maxime Courtehoux (M)

Nuclear Medicine Department, CHRU TOURS, Tours, France.

Gilles Metrard (G)

Nuclear Medicine Department, CHR ORLEANS, 14 Avenue de l'Hôpital, 45100, Orleans, France.

Maria Joao Ribeiro (MJ)

Nuclear Medicine Department, CHRU TOURS, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH